SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon’s Q3 consolidated net declines 16%

25 Jan 2012 Evaluate

Biocon has reported results for its third quarter ended December 31, 2011.

The company has posted a 69.41% fall in net profit of Rs 64.73 crore for the quarter ended December 31, 2011 as compared to Rs 211.59 crore for the same quarter in the previous year. Total income has decreased by 23.19% from Rs 515.94 crore for Q3FY11 to Rs 396.30 crore in the quarter under review.

On the consolidated basis the group has posted a net profit fall of 15.79% to Rs 84.85 crore for the quarter ended December 31, 2011 as compared to Rs 100.76 crore in the same quarter last year. Total Income of the company improved marginally by 2.65% to Rs 532.18 crore for the quarter compared to Rs 518.44 crore in the quarter, year ago.

Biocon Share Price

359.35 1.15 (0.32%)
20-Apr-2026 12:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.90
Dr. Reddys Lab 1238.60
Cipla 1239.40
Zydus Lifesciences 940.70
Lupin 2331.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×